Brief: Atea Pharmaceuticals Reports First Quarter 2022 Financial Results And Provides Business Update
10/05/2022 11:35
May 10 (Reuters) - Atea Pharmaceuticals Inc AVIR.O :
* ATEA PHARMACEUTICALS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* QTRLY DILUTED SHARE LOSS $0.51
* Q1 EARNINGS PER SHARE VIEW $-0.58 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4R1f7m
Further company coverage: AVIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM